,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2019-09-18 16:45:28,2019-09-16,ALDR,Smith Jeffrey T L,MD,M - OptEx,$4.15,32728,5272,-119%,"+$135,902",,,,,ALDR
1,D,2019-09-18 16:45:28,2019-09-16,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$18.44,-32728,5272,-86%,"-$603,504",,,,,ALDR
2,,2019-04-25 18:55:14,2019-04-23,ALDR,Hassler Randal,"EVP, Pharmaceutical Ops.",A - Grant,$0.00,7172,5434,-413%,+$0,,,,,ALDR
3,,2019-04-25 18:55:14,2019-04-25,ALDR,Hassler Randal,"EVP, Pharmaceutical Ops.",S - Sale,$13.85,-1738,5434,-24%,"-$24,067",,,,,ALDR
4,,2019-04-25 18:53:24,2019-04-23,ALDR,Benedict Larry,"EVP, PAO",A - Grant,$0.00,7055,39728,+22%,+$0,,,,,ALDR
5,,2019-04-25 18:53:24,2019-04-25,ALDR,Benedict Larry,"EVP, PAO",S - Sale,$13.65,-1734,39728,-4%,"-$23,662",,,,,ALDR
6,,2019-04-25 18:51:46,2019-04-23,ALDR,Smith Jeffrey T L,MD,A - Grant,$0.00,9288,5272,-231%,+$0,,,,,ALDR
7,,2019-04-25 18:51:46,2019-04-25,ALDR,Smith Jeffrey T L,MD,D - Sale to issuer,$13.73,-4847,5272,-48%,"-$66,526",,,,,ALDR
8,,2019-04-25 18:49:27,2019-04-23,ALDR,Lavelle Erin,COO,A - Grant,$0.00,5842,4408,-407%,+$0,,,,,ALDR
9,,2019-04-25 18:49:27,2019-04-25,ALDR,Lavelle Erin,COO,S - Sale,$13.67,-1434,4408,-25%,"-$19,599",,,,,ALDR
10,,2019-04-25 18:43:22,2019-04-23,ALDR,Bucher James B,"EVP, GC",A - Grant,$0.00,7810,9809,+391%,+$0,,,,,ALDR
11,,2019-04-25 18:43:22,2019-04-25,ALDR,Bucher James B,"EVP, GC",S - Sale,$13.85,-1897,9809,-16%,"-$26,281",,,,,ALDR
12,,2019-03-06 16:24:24,2019-03-04,ALDR,"Redmile Group, LLC",Dir,A - Grant,$11.50,1739130,8244896,+27%,"+$19,999,995",,,,,ALDR
13,D,2019-02-08 16:47:56,2018-11-30,ALDR,Latham John A,Chief Scientific Officer,A - Grant,$9.35,487,244180,0%,"+$4,553",,,,,ALDR
14,D,2019-02-08 16:43:46,2018-11-30,ALDR,Bucher James B,"EVP, GC",A - Grant,$9.35,273,3896,+8%,"+$2,553",,,,,ALDR
15,DM,2019-02-08 16:41:48,2018-05-31,ALDR,Benedict Larry,"EVP, PAO",A - Grant,$9.35,2273,34407,+7%,"+$21,253",,,,,ALDR
16,D,2018-12-04 18:39:08,2018-12-03,ALDR,Smith Jeffrey T L,MD,M - OptEx,$0.99,5044,831,-120%,"+$4,994",,,,,ALDR
17,D,2018-12-04 18:39:08,2018-12-03,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$13.84,-5044,831,-86%,"-$69,826",,,,,ALDR
18,D,2018-11-27 17:35:29,2018-05-31,ALDR,Bucher James B,"SVP, GC",A - Grant,$9.35,2000,3623,+123%,"+$18,700",,,,,ALDR
19,D,2018-11-05 17:47:54,2018-11-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,$0.99,5040,831,-120%,"+$4,990",,,,,ALDR
20,D,2018-11-05 17:47:54,2018-11-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$13.42,-5040,831,-86%,"-$67,637",,,,,ALDR
21,D,2018-11-05 17:43:15,2018-11-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$9.12,25002,243693,+11%,"+$227,954",,,,,ALDR
22,D,2018-11-05 17:43:15,2018-11-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$13.42,-25002,243693,-9%,"-$335,589",,,,,ALDR
23,D,2018-10-03 18:33:25,2018-10-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,$0.99,5040,831,-120%,"+$4,990",,,,,ALDR
24,D,2018-10-03 18:33:25,2018-10-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$15.54,-5040,831,-86%,"-$78,329",,,,,ALDR
25,D,2018-10-03 18:31:50,2018-10-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$4.36,24999,243693,+11%,"+$109,108",,,,,ALDR
26,D,2018-10-03 18:31:50,2018-10-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$15.44,-24999,243693,-9%,"-$386,006",,,,,ALDR
27,D,2018-09-06 17:08:33,2018-09-04,ALDR,Smith Jeffrey T L,MD,M - OptEx,$0.99,5040,831,-120%,"+$4,990",,,,,ALDR
28,D,2018-09-06 17:08:33,2018-09-04,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$18.00,-5040,831,-86%,"-$90,699",,,,,ALDR
29,D,2018-09-06 17:05:39,2018-09-04,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$3.47,24999,243693,+11%,"+$86,622",,,,,ALDR
30,D,2018-09-06 17:05:39,2018-09-04,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$17.99,-24999,243693,-9%,"-$449,680",,,,,ALDR
31,D,2018-08-02 17:48:16,2018-08-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,$0.99,5040,831,-120%,"+$4,990",,,,,ALDR
32,D,2018-08-02 17:48:16,2018-08-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$19.54,-5040,831,-86%,"-$98,489",,,,,ALDR
33,D,2018-08-02 17:40:08,2018-08-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$3.47,24999,243693,+11%,"+$86,622",,,,,ALDR
34,D,2018-08-02 17:40:08,2018-08-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$19.55,-24999,243693,-9%,"-$488,768",,,,,ALDR
35,D,2018-07-03 17:28:10,2018-07-02,ALDR,Smith Jeffrey T L,MD,M - OptEx,$1.38,12161,831,-107%,"+$16,739",,,,,ALDR
36,D,2018-07-03 17:28:10,2018-07-02,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$15.49,-12161,831,-94%,"-$188,364",,,,,ALDR
37,D,2018-07-03 17:22:36,2018-07-02,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$3.47,24999,243693,+11%,"+$86,622",,,,,ALDR
38,D,2018-07-03 17:22:36,2018-07-02,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$15.48,-24999,243693,-9%,"-$387,002",,,,,ALDR
39,D,2018-06-05 17:43:41,2018-06-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$4.37,24999,243693,+11%,"+$109,121",,,,,ALDR
40,D,2018-06-05 17:43:41,2018-06-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$17.86,-24999,243693,-9%,"-$446,356",,,,,ALDR
41,D,2018-06-05 17:41:52,2018-06-01,ALDR,Smith Jeffrey T L,MD,M - OptEx,$1.38,12161,831,-107%,"+$16,739",,,,,ALDR
42,D,2018-06-05 17:41:52,2018-06-01,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$17.85,-12161,831,-94%,"-$217,127",,,,,ALDR
43,D,2018-06-05 17:40:18,2018-06-01,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$0.99,22727,180189,+14%,"+$22,500",,,,,ALDR
44,D,2018-06-05 17:40:18,2018-06-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$17.84,-22727,180189,-11%,"-$405,412",,,,,ALDR
45,D,2018-05-18 17:57:47,2018-05-16,ALDR,Smith Jeffrey T L,MD,M - OptEx,$1.38,12161,831,-107%,"+$16,739",,,,,ALDR
46,D,2018-05-18 17:57:47,2018-05-16,ALDR,Smith Jeffrey T L,MD,S - Sale+OE,$15.03,-12161,831,-94%,"-$182,758",,,,,ALDR
47,DM,2017-12-18 18:28:19,2017-05-31,ALDR,Latham John A,Chief Scientific Officer,A - Grant,$10.90,805,243208,0%,"+$8,772",,,,,ALDR
48,D,2017-12-18 18:25:25,2017-11-30,ALDR,Bucher James B,"SVP, GC",A - Grant,$9.35,1623,1623,New,"+$15,175",,,,,ALDR
49,D,2017-11-15 17:54:56,2017-11-13,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$1.65,16519,177932,+10%,"+$27,256",,,,,ALDR
50,D,2017-11-15 17:54:56,2017-11-13,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$10.80,-16519,177932,-8%,"-$178,486",,,,,ALDR
51,D,2017-11-03 17:48:23,2017-11-01,ALDR,Siegall Clay B,Dir,M - OptEx,$1.30,27270,31714,+614%,"+$35,496",,,,,ALDR
52,D,2017-10-18 18:20:14,2017-10-16,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$1.65,16520,177932,+10%,"+$27,258",,,,,ALDR
53,D,2017-10-18 18:20:14,2017-10-16,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$12.33,-16520,177932,-8%,"-$203,703",,,,,ALDR
54,,2017-07-18 19:52:09,2017-07-18,ALDR,Yarno Wendy L,Dir,P - Purchase,$10.00,5000,5000,New,"+$50,000",,,,,ALDR
55,,2017-07-18 19:50:48,2017-07-18,ALDR,Dow Stephen M,Dir,P - Purchase,$10.00,25000,307190,+9%,"+$250,000",,,,,ALDR
56,D,2017-06-22 18:12:08,2017-06-20,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.99,585,831,+238%,+$579,,,,,ALDR
57,D,2017-06-22 18:12:08,2017-06-20,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$20.00,-585,831,-41%,"-$11,700",,,,,ALDR
58,D,2017-02-13 18:10:38,2017-02-09,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.65,30000,115172,+35%,"+$49,500",0.0,-3.0,-5.0,,ALDR
59,D,2017-02-13 18:10:38,2017-02-09,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$25.03,-30000,115172,-21%,"-$750,756",0.0,-3.0,-5.0,,ALDR
60,D,2017-01-31 17:32:05,2016-11-30,ALDR,Benedict Larry,"EVP, PAO",A - Grant,$20.20,742,30989,+2%,"+$14,988",2.0,13.0,17.0,,ALDR
61,D,2017-01-31 17:23:42,2016-11-30,ALDR,Schatzman Randall C,"Pres, CEO",A - Grant,$20.20,404,115172,0%,"+$8,161",2.0,13.0,17.0,,ALDR
62,D,2017-01-20 18:38:42,2017-01-18,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$1.65,1498,177932,+1%,"+$2,472",-4.0,-5.0,11.0,,ALDR
63,D,2017-01-20 18:38:42,2017-01-18,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$23.10,-1498,177932,-1%,"-$34,599",-4.0,-5.0,11.0,,ALDR
64,DM,2017-01-09 17:49:00,2017-01-05,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$1.34,9516,177932,+6%,"+$12,741",0.0,-4.0,4.0,,ALDR
65,DM,2017-01-09 17:49:00,2017-01-05,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$23.01,-9516,177932,-5%,"-$218,992",0.0,-4.0,4.0,,ALDR
66,D,2016-12-05 18:47:56,2016-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$1.65,3000,831,-138%,"+$4,950",1.0,-5.0,-4.0,,ALDR
67,D,2016-12-05 18:47:56,2016-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$22.78,-3000,831,-78%,"-$68,328",1.0,-5.0,-4.0,,ALDR
68,D,2016-12-05 18:46:33,2016-12-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.65,3636,242403,+2%,"+$5,999",1.0,-5.0,-4.0,,ALDR
69,D,2016-12-05 18:46:33,2016-12-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$22.78,-3636,242403,-1%,"-$82,812",1.0,-5.0,-4.0,,ALDR
70,D,2016-11-14 18:32:13,2016-11-09,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.65,10000,242200,+4%,"+$16,500",-3.0,-17.0,-37.0,,ALDR
71,D,2016-11-14 18:32:13,2016-11-09,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$30.18,-10000,242200,-4%,"-$301,839",-3.0,-17.0,-37.0,,ALDR
72,D,2016-11-09 18:17:59,2016-11-07,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.65,10000,114768,+10%,"+$16,500",3.0,14.0,-31.0,-41.0,ALDR
73,D,2016-11-09 18:17:59,2016-11-07,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$25.16,-10000,114768,-8%,"-$251,605",3.0,14.0,-31.0,-41.0,ALDR
74,D,2016-11-03 18:39:46,2016-11-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$1.65,3000,0,-100%,"+$4,950",8.0,30.0,2.0,-7.0,ALDR
75,D,2016-11-03 18:39:46,2016-11-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$24.34,-3000,0,-100%,"-$73,032",8.0,30.0,2.0,-7.0,ALDR
76,,2016-10-19 17:51:01,2016-10-17,ALDR,Litton Mark James,Chief Business Officer,S - Sale,$27.50,-6000,125567,-5%,"-$164,998",7.0,0.0,5.0,-26.0,ALDR
77,D,2016-10-11 16:56:27,2016-05-31,ALDR,Benedict Larry,"EVP, PAO",A - Grant,$8.50,2000,30247,+7%,"+$17,000",-6.0,-8.0,-14.0,-33.0,ALDR
78,D,2016-10-05 19:02:54,2016-10-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$1.65,3000,0,-100%,"+$4,950",-4.0,-4.0,-25.0,-39.0,ALDR
79,D,2016-10-05 19:02:54,2016-10-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$31.14,-3000,0,-100%,"-$93,415",-4.0,-4.0,-25.0,-39.0,ALDR
80,D,2016-10-05 18:54:32,2016-10-03,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.27,8181,114768,+8%,"+$10,349",-4.0,-4.0,-25.0,-39.0,ALDR
81,D,2016-10-05 18:54:32,2016-10-03,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$31.15,-8181,114768,-7%,"-$254,811",-4.0,-4.0,-25.0,-39.0,ALDR
82,D,2016-10-05 18:53:02,2016-10-03,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.65,10000,242200,+4%,"+$16,500",-4.0,-4.0,-25.0,-39.0,ALDR
83,D,2016-10-05 18:53:02,2016-10-03,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$31.32,-10000,242200,-4%,"-$313,152",-4.0,-4.0,-25.0,-39.0,ALDR
84,D,2016-09-06 18:39:21,2016-09-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.65,10000,242200,+4%,"+$16,500",1.0,-1.0,-2.0,-32.0,ALDR
85,D,2016-09-06 18:39:21,2016-09-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$32.49,-10000,242200,-4%,"-$324,949",1.0,-1.0,-2.0,-32.0,ALDR
86,D,2016-09-06 18:36:22,2016-09-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.27,10000,114768,+10%,"+$12,650",1.0,-1.0,-2.0,-32.0,ALDR
87,D,2016-09-06 18:36:22,2016-09-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$32.48,-10000,114768,-8%,"-$324,820",1.0,-1.0,-2.0,-32.0,ALDR
88,D,2016-09-06 18:34:24,2016-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$1.65,3000,0,-100%,"+$4,950",1.0,-1.0,-2.0,-32.0,ALDR
89,D,2016-09-06 18:34:24,2016-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$32.49,-3000,0,-100%,"-$97,483",1.0,-1.0,-2.0,-32.0,ALDR
90,D,2016-08-17 18:55:41,2016-08-15,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$1.65,3000,0,-100%,"+$4,950",1.0,10.0,7.0,-20.0,ALDR
91,D,2016-08-17 18:55:41,2016-08-15,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$31.17,-3000,0,-100%,"-$93,512",1.0,10.0,7.0,-20.0,ALDR
92,D,2016-08-03 18:42:07,2016-08-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.27,10000,229552,+5%,"+$12,650",-1.0,-2.0,5.0,-35.0,ALDR
93,D,2016-08-03 18:42:07,2016-08-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$31.15,-10000,229552,-4%,"-$311,513",-1.0,-2.0,5.0,-35.0,ALDR
94,D,2016-08-03 18:33:10,2016-08-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.65,10000,242200,+4%,"+$16,500",-1.0,-2.0,5.0,-35.0,ALDR
95,D,2016-08-03 18:33:10,2016-08-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$31.19,-10000,242200,-4%,"-$311,948",-1.0,-2.0,5.0,-35.0,ALDR
96,DM,2016-07-28 18:37:15,2016-07-26,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.65,10000,242200,+4%,"+$16,500",5.0,3.0,4.0,-35.0,ALDR
97,DM,2016-07-28 18:37:15,2016-07-26,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$30.14,-10000,242200,-4%,"-$301,415",5.0,3.0,4.0,-35.0,ALDR
98,D,2016-07-27 18:19:26,2016-07-25,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.27,10000,114768,+10%,"+$12,650",0.0,-2.0,2.0,-35.0,ALDR
99,D,2016-07-27 18:19:26,2016-07-25,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$28.08,-10000,114768,-8%,"-$280,805",0.0,-2.0,2.0,-35.0,ALDR
100,D,2016-07-14 19:14:48,2016-07-12,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$0.39,25000,183567,+16%,"+$9,625",1.0,4.0,20.0,-20.0,ALDR
101,,2016-06-15 19:02:34,2016-06-13,ALDR,Litton Mark James,Chief Business Officer,S - Sale,$28.94,-6000,102567,-6%,"-$173,664",-1.0,-11.0,-10.0,-23.0,ALDR
102,D,2016-06-07 19:32:10,2016-06-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$1.27,16090,0,-100%,"+$20,354",-2.0,-7.0,-16.0,-26.0,ALDR
103,D,2016-06-07 19:32:10,2016-06-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$30.20,-16090,0,-100%,"-$485,933",-2.0,-7.0,-16.0,-26.0,ALDR
104,D,2016-06-03 19:16:18,2016-06-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.27,10000,114768,+10%,"+$12,650",7.0,0.0,-11.0,-19.0,ALDR
105,D,2016-06-03 19:16:18,2016-06-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$29.65,-10000,114768,-8%,"-$296,544",7.0,0.0,-11.0,-19.0,ALDR
106,D,2016-06-03 19:11:59,2016-06-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.65,10000,242200,+4%,"+$16,500",7.0,0.0,-11.0,-19.0,ALDR
107,D,2016-06-03 19:11:59,2016-06-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$30.02,-10000,242200,-4%,"-$300,216",7.0,0.0,-11.0,-19.0,ALDR
108,DM,2016-06-01 19:53:44,2016-05-27,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.35,40000,242200,+20%,"+$54,100",6.0,3.0,-19.0,-21.0,ALDR
109,DM,2016-06-01 19:53:44,2016-05-27,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$30.04,-40000,242200,-14%,"-$1,201,619",6.0,3.0,-19.0,-21.0,ALDR
110,DM,2016-06-01 19:49:53,2016-05-27,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$0.39,25000,164567,+18%,"+$9,625",6.0,3.0,-19.0,-21.0,ALDR
111,DM,2016-06-01 19:49:53,2016-05-27,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$30.05,-25000,164567,-13%,"-$751,259",6.0,3.0,-19.0,-21.0,ALDR
112,DM,2016-05-24 20:13:45,2016-05-20,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$1.27,10000,112947,+10%,"+$12,650",-2.0,6.0,-11.0,1.0,ALDR
113,DM,2016-05-24 20:13:45,2016-05-20,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$28.02,-10000,112947,-8%,"-$280,175",-2.0,6.0,-11.0,1.0,ALDR
114,DM,2016-04-18 18:40:11,2016-04-14,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$0.68,30000,112947,+36%,"+$20,350",-2.0,3.0,-9.0,1.0,ALDR
115,DM,2016-04-18 18:40:11,2016-04-14,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$28.07,-30000,112947,-21%,"-$841,967",-2.0,3.0,-9.0,1.0,ALDR
116,D,2016-02-02 19:00:44,2015-11-30,ALDR,Benedict Larry,SVP Finance,A - Grant,$8.50,2000,28247,+8%,"+$17,000",-4.0,-20.0,-15.0,22.0,ALDR
117,D,2016-01-06 20:40:45,2016-01-04,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$0.39,25000,163718,+18%,"+$9,625",-4.0,-9.0,-24.0,-17.0,ALDR
118,D,2016-01-06 20:40:45,2016-01-04,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$31.40,-25000,163718,-13%,"-$784,951",-4.0,-9.0,-24.0,-17.0,ALDR
119,D,2016-01-06 20:37:58,2016-01-04,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$1.27,10000,241726,+4%,"+$12,650",-4.0,-9.0,-24.0,-17.0,ALDR
120,D,2016-01-06 20:37:58,2016-01-04,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$31.41,-10000,241726,-4%,"-$314,137",-4.0,-9.0,-24.0,-17.0,ALDR
121,D,2016-01-06 20:35:56,2016-01-04,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$0.39,10000,111579,+10%,"+$3,850",-4.0,-9.0,-24.0,-17.0,ALDR
122,D,2016-01-06 20:35:56,2016-01-04,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$31.47,-10000,111579,-8%,"-$314,747",-4.0,-9.0,-24.0,-17.0,ALDR
123,D,2015-12-03 21:02:48,2015-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,4272,0,-100%,"+$1,645",1.0,-4.0,-11.0,-17.0,ALDR
124,D,2015-12-03 21:02:48,2015-12-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$37.24,-4272,0,-100%,"-$159,104",1.0,-4.0,-11.0,-17.0,ALDR
125,D,2015-12-03 21:00:57,2015-12-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4550,241726,+2%,"+$1,752",1.0,-4.0,-11.0,-17.0,ALDR
126,D,2015-12-03 21:00:57,2015-12-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$37.24,-4550,241726,-2%,"-$169,452",1.0,-4.0,-11.0,-17.0,ALDR
127,D,2015-12-03 20:59:08,2015-12-01,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$0.39,10000,111579,+10%,"+$3,850",1.0,-4.0,-11.0,-17.0,ALDR
128,D,2015-12-03 20:59:08,2015-12-01,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$37.24,-10000,111579,-8%,"-$372,431",1.0,-4.0,-11.0,-17.0,ALDR
129,,2015-12-02 17:56:19,2015-11-30,ALDR,Dow Stephen M,Dir,S - Sale,$37.11,-88,282190,0%,"-$3,266",-4.0,-6.0,-12.0,-14.0,ALDR
130,D,2015-11-04 21:44:52,2015-11-02,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,241265,+2%,"+$1,750",-3.0,-9.0,-7.0,-35.0,ALDR
131,D,2015-11-04 21:44:52,2015-11-02,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$33.69,-4545,241265,-2%,"-$153,137",-3.0,-9.0,-7.0,-35.0,ALDR
132,D,2015-11-04 21:42:25,2015-11-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",-3.0,-9.0,-7.0,-35.0,ALDR
133,D,2015-11-04 21:42:25,2015-11-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$33.67,-3900,0,-100%,"-$131,299",-3.0,-9.0,-7.0,-35.0,ALDR
134,D,2015-11-04 21:40:03,2015-11-02,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$0.39,10000,109921,+10%,"+$3,850",-3.0,-9.0,-7.0,-35.0,ALDR
135,D,2015-11-04 21:40:03,2015-11-02,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$33.71,-10000,109921,-8%,"-$337,066",-3.0,-9.0,-7.0,-35.0,ALDR
136,D,2015-10-05 18:21:26,2015-10-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,241265,+2%,"+$1,750",-8.0,-19.0,0.0,-32.0,ALDR
137,D,2015-10-05 18:21:26,2015-10-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$32.26,-4545,241265,-2%,"-$146,603",-8.0,-19.0,0.0,-32.0,ALDR
138,,2015-10-05 18:19:29,2015-10-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale,$32.27,-7500,162919,-4%,"-$242,002",-8.0,-19.0,0.0,-32.0,ALDR
139,D,2015-10-05 18:16:38,2015-10-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",-8.0,-19.0,0.0,-32.0,ALDR
140,D,2015-10-05 18:16:38,2015-10-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$32.25,-3900,0,-100%,"-$125,778",-8.0,-19.0,0.0,-32.0,ALDR
141,D,2015-09-28 18:19:36,2015-09-24,ALDR,Benedict Larry,SVP Finance,M - OptEx,$3.28,24981,26247,>999%,"+$82,060",-5.0,12.0,-3.0,-19.0,ALDR
142,D,2015-09-28 18:14:06,2015-09-24,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.99,31818,241265,+15%,"+$31,500",-5.0,12.0,-3.0,-19.0,ALDR
143,D,2015-09-28 18:11:37,2015-09-24,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$1.27,12764,170419,+8%,"+$16,146",-5.0,12.0,-3.0,-19.0,ALDR
144,D,2015-09-03 18:09:39,2015-09-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,209447,+2%,"+$1,750",1.0,2.0,-12.0,-49.0,ALDR
145,D,2015-09-03 18:09:39,2015-09-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$38.52,-4545,209447,-2%,"-$175,059",1.0,2.0,-12.0,-49.0,ALDR
146,D,2015-09-03 18:01:12,2015-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",1.0,2.0,-12.0,-49.0,ALDR
147,D,2015-09-03 18:01:12,2015-09-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$38.50,-3900,0,-100%,"-$150,165",1.0,2.0,-12.0,-49.0,ALDR
148,,2015-09-02 14:51:59,2015-08-31,ALDR,Srb Associates IX L.P.,Affiliate,S - Sale,$38.75,-16218,88,-99%,"-$628,460",6.0,6.0,-15.0,-48.0,ALDR
149,,2015-09-02 14:51:26,2015-08-31,ALDR,Dow Stephen M,Dir,S - Sale,$38.75,-16218,282278,-5%,"-$628,460",6.0,6.0,-15.0,-48.0,ALDR
150,M,2015-08-13 19:51:43,2015-08-11,ALDR,Srb Associates IX L.P.,Affiliate,S - Sale,$40.23,-212467,1828276,-10%,"-$8,548,172",-3.0,-1.0,10.0,-44.0,ALDR
151,M,2015-08-13 19:50:48,2015-08-11,ALDR,Jaggers John V,Affiliate,S - Sale,$40.23,-212467,20764,-91%,"-$8,548,172",-3.0,-1.0,10.0,-44.0,ALDR
152,M,2015-08-13 19:49:47,2015-08-11,ALDR,Dow Stephen M,Dir,S - Sale,$40.23,-212467,298496,-42%,"-$8,548,172",-3.0,-1.0,10.0,-44.0,ALDR
153,D,2015-08-05 18:27:38,2015-08-03,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,209447,+2%,"+$1,750",-3.0,-11.0,-9.0,-46.0,ALDR
154,D,2015-08-05 18:27:38,2015-08-03,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$45.62,-4545,209447,-2%,"-$207,322",-3.0,-11.0,-9.0,-46.0,ALDR
155,D,2015-08-05 18:26:03,2015-08-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",-3.0,-11.0,-9.0,-46.0,ALDR
156,D,2015-08-05 18:26:03,2015-08-03,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$45.64,-3900,0,-100%,"-$178,003",-3.0,-11.0,-9.0,-46.0,ALDR
157,D,2015-07-06 18:05:47,2015-07-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",-7.0,-5.0,-14.0,-37.0,ALDR
158,D,2015-07-06 18:05:47,2015-07-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$51.18,-3900,0,-100%,"-$199,616",-7.0,-5.0,-14.0,-37.0,ALDR
159,D,2015-07-06 18:02:34,2015-07-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,209447,+2%,"+$1,750",-7.0,-5.0,-14.0,-37.0,ALDR
160,D,2015-07-06 18:02:34,2015-07-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$51.13,-4545,209447,-2%,"-$232,381",-7.0,-5.0,-14.0,-37.0,ALDR
161,,2015-07-06 17:59:58,2015-07-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale,$51.10,-7500,157655,-5%,"-$383,219",-7.0,-5.0,-14.0,-37.0,ALDR
162,D,2015-06-16 18:15:07,2015-06-12,ALDR,Benedict Larry,SVP Finance,M - OptEx,$1.65,25454,1266,-105%,"+$41,999",-2.0,-3.0,6.0,-27.0,ALDR
163,D,2015-06-16 18:15:07,2015-06-12,ALDR,Benedict Larry,SVP Finance,S - Sale+OE,$47.46,-25454,1266,-95%,"-$1,208,090",-2.0,-3.0,6.0,-27.0,ALDR
164,D,2015-06-08 19:05:34,2015-06-04,ALDR,Litton Mark James,Chief Business Officer,M - OptEx,$0.39,25000,165155,+18%,"+$9,625",0.0,2.0,5.0,-23.0,ALDR
165,D,2015-06-08 19:05:34,2015-06-04,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$44.27,-25000,165155,-13%,"-$1,106,853",0.0,2.0,5.0,-23.0,ALDR
166,D,2015-06-08 19:03:16,2015-06-04,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,25000,209447,+14%,"+$9,625",0.0,2.0,5.0,-23.0,ALDR
167,D,2015-06-08 19:03:16,2015-06-04,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$44.18,-25000,209447,-11%,"-$1,104,463",0.0,2.0,5.0,-23.0,ALDR
168,D,2015-06-03 20:04:13,2015-06-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",7.0,8.0,18.0,-13.0,ALDR
169,D,2015-06-03 20:04:13,2015-06-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$41.53,-3900,0,-100%,"-$161,969",7.0,8.0,18.0,-13.0,ALDR
170,D,2015-06-03 19:59:00,2015-06-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,209447,+2%,"+$1,750",7.0,8.0,18.0,-13.0,ALDR
171,D,2015-06-03 19:59:00,2015-06-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$41.53,-4545,209447,-2%,"-$188,757",7.0,8.0,18.0,-13.0,ALDR
172,D,2015-05-28 18:15:32,2015-05-26,ALDR,Schatzman Randall C,"Pres, CEO",M - OptEx,$0.39,50000,109921,+83%,"+$19,250",1.0,2.0,8.0,-13.0,ALDR
173,D,2015-05-28 18:15:32,2015-05-26,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$38.96,-50000,109921,-31%,"-$1,948,085",1.0,2.0,8.0,-13.0,ALDR
174,DM,2015-05-26 19:53:32,2015-05-21,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.06,61818,0,-100%,"+$3,400",5.0,5.0,20.0,-11.0,ALDR
175,DM,2015-05-26 19:53:32,2015-05-21,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$38.86,-61818,0,-100%,"-$2,402,523",5.0,5.0,20.0,-11.0,ALDR
176,AD,2015-05-21 18:30:30,2015-05-20,ALDR,Dow Stephen M,"Dir, 10%",S - Sale+OE,$40.39,-8462,4313992,0%,"-$341,820",0.0,8.0,19.0,-9.0,ALDR
177,D,2015-05-21 18:20:07,2015-05-19,ALDR,Benedict Larry,SVP Finance,M - OptEx,$1.65,20000,663,-103%,"+$33,000",0.0,8.0,19.0,-9.0,ALDR
178,D,2015-05-21 18:20:07,2015-05-19,ALDR,Benedict Larry,SVP Finance,S - Sale+OE,$38.86,-20000,663,-97%,"-$777,196",0.0,8.0,19.0,-9.0,ALDR
179,,2015-05-21 17:53:56,2015-05-19,ALDR,Srb Associates IX L.P.,10%,S - Sale,$37.02,-1136100,4048874,-22%,"-$42,059,899",0.0,8.0,19.0,-9.0,ALDR
180,,2015-05-21 15:34:21,2015-05-21,ALDR,Dow Stephen M,Dir,S - Sale,$65.69,-20000,334072,-6%,"-$1,313,846",-5.0,4.0,15.0,-14.0,ALDR
181,D,2015-05-18 20:51:55,2015-05-14,ALDR,Siegall Clay B,Dir,M - OptEx,$0.33,18181,4444,-132%,"+$6,000",-1.0,-3.0,17.0,-13.0,ALDR
182,DM,2015-05-18 20:51:55,2015-05-14,ALDR,Siegall Clay B,Dir,S - Sale+OE,$37.62,-38181,4444,-90%,"-$1,436,495",-1.0,-3.0,17.0,-13.0,ALDR
183,D,2015-05-05 18:22:21,2015-05-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",4.0,27.0,57.0,17.0,ALDR
184,D,2015-05-05 18:22:21,2015-05-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$25.67,-3900,0,-100%,"-$100,130",4.0,27.0,57.0,17.0,ALDR
185,D,2015-05-05 18:18:22,2015-05-01,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,208988,+2%,"+$1,750",4.0,27.0,57.0,17.0,ALDR
186,D,2015-05-05 18:18:22,2015-05-01,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$25.67,-4545,208988,-2%,"-$116,663",4.0,27.0,57.0,17.0,ALDR
187,D,2015-04-03 18:02:54,2015-04-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",2.0,4.0,3.0,22.0,ALDR
188,D,2015-04-03 18:02:54,2015-04-01,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$27.43,-3900,0,-100%,"-$106,995",2.0,4.0,3.0,22.0,ALDR
189,,2015-04-03 17:58:59,2015-04-01,ALDR,Litton Mark James,Chief Business Officer,S - Sale,$27.41,-7500,164359,-4%,"-$205,553",2.0,4.0,3.0,22.0,ALDR
190,DM,2015-04-01 20:36:45,2015-03-30,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,19045,208988,+10%,"+$7,332",-2.0,2.0,-7.0,7.0,ALDR
191,DM,2015-04-01 20:36:45,2015-03-30,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$29.54,-19045,208988,-8%,"-$562,518",-2.0,2.0,-7.0,7.0,ALDR
192,D,2015-03-04 17:35:58,2015-03-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",-3.0,3.0,3.0,46.0,ALDR
193,D,2015-03-04 17:35:58,2015-03-02,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$26.25,-3900,0,-100%,"-$102,357",-3.0,3.0,3.0,46.0,ALDR
194,D,2015-03-04 17:32:33,2015-03-02,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,4545,208988,+2%,"+$1,750",-3.0,3.0,3.0,46.0,ALDR
195,D,2015-03-04 17:32:33,2015-03-02,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$26.26,-4545,208988,-2%,"-$119,340",-3.0,3.0,3.0,46.0,ALDR
196,D,2015-01-28 18:09:21,2014-11-28,ALDR,Benedict Larry,SVP Finance,A - Grant,$8.50,663,663,New,"+$5,636",-4.0,-9.0,-1.0,68.0,ALDR
197,DM,2015-01-28 18:01:38,2015-01-26,ALDR,Smith Jeffrey T L,SVP Translational Medicine,M - OptEx,$0.39,3900,0,-100%,"+$1,502",-4.0,-9.0,-1.0,68.0,ALDR
198,DM,2015-01-28 18:01:38,2015-01-26,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale+OE,$28.01,-3900,0,-100%,"-$109,237",-4.0,-9.0,-1.0,68.0,ALDR
199,DM,2015-01-28 17:56:52,2015-01-26,ALDR,Litton Mark James,Chief Business Officer,S - Sale+OE,$28.18,-7500,171859,-4%,"-$211,334",-4.0,-9.0,-1.0,68.0,ALDR
200,DM,2015-01-28 17:54:35,2015-01-26,ALDR,Latham John A,Chief Scientific Officer,M - OptEx,$0.39,15045,208988,+8%,"+$5,792",-4.0,-9.0,-1.0,68.0,ALDR
201,DM,2015-01-28 17:54:35,2015-01-26,ALDR,Latham John A,Chief Scientific Officer,S - Sale+OE,$28.33,-15045,208988,-7%,"-$426,286",-4.0,-9.0,-1.0,68.0,ALDR
202,DM,2015-01-28 17:51:52,2015-01-26,ALDR,Schatzman Randall C,"Pres, CEO",S - Sale+OE,$28.42,-100000,109921,-48%,"-$2,842,399",-4.0,-9.0,-1.0,68.0,ALDR
203,M,2014-11-25 18:13:57,2014-11-21,ALDR,Smith Jeffrey T L,SVP Translational Medicine,S - Sale,$16.08,-29090,0,-100%,"-$467,853",1.0,3.0,52.0,150.0,ALDR
204,,2014-11-24 18:37:52,2014-11-20,ALDR,Litton Mark James,Chief Business Officer,S - Sale,$15.63,-30000,178484,-14%,"-$469,011",-1.0,-8.0,53.0,159.0,ALDR
205,D,2014-05-15 17:45:28,2014-05-13,ALDR,"Delphi Management Partners Vii, L.L.C.",10%,C - Converted deriv,$0.00,2488532,5673599,-30%,$0,0.0,-1.0,102.0,71.0,ALDR
206,D,2014-05-15 17:45:28,2014-05-13,ALDR,"Delphi Management Partners Vii, L.L.C.",10%,P - Purchase,$10.00,350000,5673599,+7%,"+$3,500,000",0.0,-1.0,102.0,71.0,ALDR
207,D,2014-05-15 17:43:10,2014-05-13,ALDR,Pakianathan Deepika,"Dir, 10%",C - Converted deriv,$0.00,2488532,5673599,-30%,$0,0.0,-1.0,102.0,71.0,ALDR
208,D,2014-05-15 17:43:10,2014-05-13,ALDR,Pakianathan Deepika,"Dir, 10%",P - Purchase,$10.00,350000,5673599,+7%,"+$3,500,000",0.0,-1.0,102.0,71.0,ALDR
209,D,2014-05-15 17:20:42,2014-05-13,ALDR,Siegall Clay B,Dir,C - Converted deriv,$0.00,24444,24444,-50%,$0,0.0,-1.0,102.0,71.0,ALDR
210,D,2014-05-15 17:18:15,2014-05-13,ALDR,Montgomery Alan Bruce,Dir,C - Converted deriv,$0.00,6628,9628,-41%,$0,0.0,-1.0,102.0,71.0,ALDR
211,D,2014-05-15 17:18:15,2014-05-13,ALDR,Montgomery Alan Bruce,Dir,P - Purchase,$10.00,3000,9628,+45%,"+$30,000",0.0,-1.0,102.0,71.0,ALDR
212,D,2014-05-15 17:16:24,2014-05-13,ALDR,"H.I.G. Venture Partners Ii, L.P.",10%,C - Converted deriv,$0.00,2581976,516395,-83%,$0,0.0,-1.0,102.0,71.0,ALDR
213,D,2014-05-15 17:14:46,2014-05-13,ALDR,Davidson Aaron,Dir,C - Converted deriv,$0.00,2581976,2581976,-50%,$0,0.0,-1.0,102.0,71.0,ALDR
214,D,2014-05-15 17:09:52,2014-05-13,ALDR,Ventures West 8 Limited Partnership,10%,C - Converted deriv,$0.00,3219528,3469528,-48%,$0,0.0,-1.0,102.0,71.0,ALDR
215,D,2014-05-15 17:09:52,2014-05-13,ALDR,Ventures West 8 Limited Partnership,10%,P - Purchase,$10.00,250000,3469528,+8%,"+$2,500,000",0.0,-1.0,102.0,71.0,ALDR
216,D,2014-05-15 17:08:30,2014-05-13,ALDR,Bridger Gary,Dir,C - Converted deriv,$0.00,3219528,3469528,-48%,$0,0.0,-1.0,102.0,71.0,ALDR
217,D,2014-05-15 17:08:30,2014-05-13,ALDR,Bridger Gary,Dir,P - Purchase,$10.00,250000,3469528,+8%,"+$2,500,000",0.0,-1.0,102.0,71.0,ALDR
218,D,2014-05-15 12:08:56,2014-05-13,ALDR,Jaggers John V,10%,C - Converted deriv,$0.00,5193436,5193436,-50%,$0,0.0,-1.0,102.0,71.0,ALDR
219,D,2014-05-15 12:08:35,2014-05-13,ALDR,Dow Stephen M,"Dir, 10%",C - Converted deriv,$0.00,5458554,5458554,-50%,$0,0.0,-1.0,102.0,71.0,ALDR
220,D,2014-05-15 12:08:12,2014-05-13,ALDR,Srb Associates IX L.P.,10%,C - Converted deriv,$0.00,5184974,5184974,-50%,$0,0.0,-1.0,102.0,71.0,ALDR
221,D,2014-05-14 17:48:13,2014-05-13,ALDR,"Tpg Group Holdings (Sbs) Advisors, Inc.",10%,C - Converted deriv,$0.00,2488533,2488533,-50%,$0,0.0,1.0,86.0,68.0,ALDR
222,D,2014-05-14 16:24:17,2014-05-13,ALDR,Novo A/s,"SEE REMARKS, 10%",C - Converted deriv,$0.00,2651183,3201183,-45%,$0,0.0,1.0,86.0,68.0,ALDR
223,D,2014-05-14 16:24:17,2014-05-13,ALDR,Novo A/s,"SEE REMARKS, 10%",P - Purchase,$10.00,550000,3201183,+21%,"+$5,500,000",0.0,1.0,86.0,68.0,ALDR
